优甲乐替代疗法对妊娠合并甲减患者母婴妊娠结局的影响

Effect of Urtolol Replacement Therapy on Maternal and Infant Pregnancy Outcome in Pregnant Patients with Hypothyroidism

探究了采用左甲状腺素钠治疗妊娠合并甲减的治疗效果。将青海省西宁市第一人民医院产科于2019年2月—2021年2月收治的68例妊娠合并甲减产妇作为观察对象,并且将其分成新方案组和传统方案组,分别使用优甲乐替代疗法治疗和不使用左甲状腺素钠替代治疗,对比两种治疗方法效果。在新方案组和传统方案组妊娠并发症发生率对比中,新方案组是11.76%,传统方案组是38.23%,(χ^(2)=23.631,P=0.000)结果有统计学差异;在新方案组和传统方案组新生儿不良结局发生率对比中,新方案组是11.76%,传统方案组是35.29%,(χ^(2)=22.419,P=0.000)结果有统计学差异。研究发现,妊娠合并甲减患者采用优甲乐替代治疗效果较好,并发症发生率低,胎儿结局良好,该方法可推广。

To observe the therapeutic effect of levothyroxine sodium on pregnancy with hypothyroidism.68 pregnant women with hypothyroidism admitted to the Department of Obstetrics of the First People’s Hospital of Xining from February 2019 to February 2021 were observed,and they were divided into a new scheme group and a traditional scheme group.They were treated with euthyrol replacement therapy and without levothyroxine sodium replacement therapy,respectively,to compare the effects of the two treatment methods.The incidence of pregnancy complications between the new regimen group and the traditional regimen group was 11.76%and 38.23%in the traditional regimen group(χ^(2)=23.631,P=0.000),and the results were different.The incidence of adverse outcomes in neonates in the new regimen group and the traditional regimen group was 11.76%and 35.29%in the traditional regimen group(χ^(2)=22.419,P=0.000),and the results were different.The study found that the replacement therapy of eugal for pregnant women with hypothyroidism was effective,the incidence of complications was low,and the fetal outcome was good.This method can be popularized.